Extended release formulations of cannabinoids
AssigneeGlatt GmbH
InventorsReinhard Nowak, Zafar Iqbal, Neha Chavan
Life of this patent
Estimating the term…
Abstract
Compositions for the extended release of one or more cannabinoids, in which the compositions comprise a population of particles. Each particle may comprise the one or more cannabinoids, one or more drug-releasing agents, and a core. The APIs may be a cannabinoid, such as cannabidiol or Δ9-tetrahydrocannabinol. The core may comprise an inert material. The one or more cannabinoids may comprise Δ9-tetrahydrocannabinol, cannabidiol, or a combination thereof.
Claims25
A composition for extended release of one or more cannabinoids, the composition comprising a population of particles, wherein each particle comprises:
- (a) the one or more cannabinoids;
- (b) one or more drug-releasing agents;
- and
- (c) a core,
- wherein the composition releases the one or more cannabinoids over a period of at least 6 hours.
(canceled)
(canceled)
(canceled)
20-22. (canceled)
A composition for extended release of one or more cannabinoids, the composition comprising a population of particles, wherein each particle comprises:
- (a) about 1% to about 20% w/w of the one or more cannabinoids;
- (b) about 25% to about 50% w/w of one or more drug-releasing agents;
- (d) about 35% to about 65% w/w of a core;
- wherein the composition releases the one or more cannabinoids over a period of at least 6 hours.
24-26. (canceled)
Dependencies are inferred from the claim text.